Investor Relations

CURRENT POSTS

Information regarding Flerie’s and Toleranzia’s agreement on a merger plan to take Toleranzia private

Press releases

• Flerie and Toleranzia have agreed on a merger plan to take Toleranzia private (2025-03-25 10:30:00)
• Statement by the Board of Directors of Toleranzia in view of the merger offer by Flerie (2025-03-25 10:32:00)
• Notice of Extraordinary General Meeting in Toleranzia AB (2025-04-04 08:30:00)

Documents

• Merger plan (2025-03-25) (in Swedish)
• Toleranzia AB_Auditor’s opinion on merger plan (2025-03-25) (in Swedish)
• Flerie AB_Auditor’s opinion on merger plan (2025-03-25) (in Swedish)
• Merger document (2025-04-04) (in Swedish)
• Toleranzia AB_Interim Report January-June 2024
• Toleranzia AB_Annual Report 2023
• Toleranzia AB_Annual Report 2022
• Toleranzia AB_Annual Report 2021
• Flerie Invest AB_Interim Report January-June 2024 (in Swedish)
• Flerie Invest AB_Annual Report 2023
• Flerie Invest AB_Annual Report 2022
• Flerie Invest AB_Annual Report 2021 (in Swedish)
• Flerie AB (previously InDex Pharmaceuticals)_Annual Report 2023
• Flerie AB (previously InDex Pharmaceuticals)_Annual Report 2022
• Flerie AB (previously InDex Pharmaceuticals)_Annual Report 2021

PREVIOUS POSTS

Information regarding Flerie Invest’s mandatory bid to the shareholders of Toleranzia

• Flerie Invest AB has announced a mandatory bid to the shareholders of Toleranzia AB (2022-11-14 08:35:00)
• Statement from the Board of Directors of Toleranzia AB regarding Flerie Invest’s mandatory bid (2022-11-28 17:40:00)

The bid document and application form relating to the bid are available on Hagberg Aneborn’s website www.hagberganeborn.se and on Flerie Invest’s website www.flerie.com.

For further information on the mandatory bid, please visit Flerie Invest’s website, www.flerie.com.